Layoffs at Novartis
- Layoff events
- 14
- verified and sourced
- Roles reported
- At least 2,564
- events with no figure are not in this number
- Announced between
- Aug 2023 to Sep 2026
- Reported by
- Novartis, Reuters, Fierce Pharma, New Jersey Department of Labor, BioSpace, New Jersey Department of Labor and Workforce Development, California Employment Development Department, WARNTracker / U.S. Department of Labor WARN data, and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Novartis: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Novartis |
Site closure
Novartis said planned changes at its Kleinbasel operations could affect around 130 jobs as it relocates laboratory activities and plans to stop small-volume biologics production there. |
130 | Not known | Kleinbasel, Basel, Switzerland | ||
| Novartis |
Restructuring
Novartis disclosed a fourth 2026 East Hanover workforce reduction affecting 322 employees as it changed field sales, patient support and marketing organizations. |
322 | Not known | U.S. headquarters, East Hanover, United States | ||
| Novartis |
Restructuring
Novartis disclosed a third East Hanover workforce reduction affecting 76 employees, including roles in its biomedical research organization. |
76 | Not known | U.S. headquarters, East Hanover, United States | ||
| Novartis |
Site closure
Novartis announced plans to close its Wehr production site by the end of 2028, a move expected to eliminate approximately 220 jobs. |
220 | Not known | Wehr production site, Wehr, Germany | ||
| Novartis |
Restructuring
Novartis disclosed a separate East Hanover round affecting 60 employees as it adjusted U.S. oncology, rheumatology, dermatology and neuroscience field sales teams. |
60 | Not known | U.S. headquarters, East Hanover, United States | ||
| Novartis |
Restructuring
Novartis disclosed a first 2026 East Hanover workforce reduction affecting 114 employees, with separations beginning June 26 and continuing through November. |
114 | Not known | U.S. headquarters, East Hanover, United States | ||
| Novartis |
Restructuring
Novartis announced planned changes to Swiss manufacturing that could eliminate approximately 550 permanent positions by the end of 2027, subject to consultation. |
550 | Not known | Stein, Switzerland |
1 source for Novartis |
|
| Novartis |
Restructuring
Novartis announced a 58-position reduction in its U.S. medical-affairs organization centered on East Hanover, New Jersey. |
58 | Not known | East Hanover, NJ, East Hanover, United States | ||
| Novartis |
Restructuring
Novartis disclosed a New Jersey WARN round affecting 427 U.S. employees reporting to its East Hanover headquarters as it reworked its cardiovascular commercialization model. |
427 | Not known | U.S. headquarters, East Hanover, United States | ||
| Novartis |
Site closure
Novartis filed California WARN notices covering 35 positions at its Campus Point operation in San Diego as part of a permanent site closure. |
35 | Not known | 10210 Campus Point Drive #350, San Diego, United States | ||
| Novartis |
Merger or acquisition
Novartis announced the closure of MorphoSys sites in Munich and Boston, affecting approximately 330 roles following the acquisition. |
330 | Not known | MorphoSys sites in Munich and Boston |
1 source for Novartis |
|
| Novartis |
Restructuring
Novartis disclosed 139 layoffs at its East Hanover, New Jersey headquarters, primarily affecting commercial field roles. |
139 | Not known | U.S. headquarters, East Hanover, United States |
1 source for Novartis |
|
| Novartis |
Restructuring
Novartis announced plans to reshape its global development organization, including around 440 positions in Switzerland and up to 240 roles in the United States. |
Not known | Not known | Company-wide |
1 source for Novartis |
|
| Novartis |
Restructuring
Novartis announced 103 layoffs at its East Hanover, New Jersey headquarters, with the cuts scheduled to take effect in November. |
103 | Not known | U.S. headquarters, East Hanover, United States |
1 source for Novartis |
Where this comes from
Every cut listed for Novartis was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Novartis? Tell us on our Discord and we will check it.